Related Experiment Video
Updated: Dec 10, 2025

A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
Bilateral Pulmonary Embolism in a Discharged Patient With Resolved COVID-19 Pneumonia
Mrunal Koche1, Samuel Bechmann2, Ivie S Omoruyi1
1Emergency Department, Wyckoff Heights Medical Center, Brooklyn, USA.
Abstract:
Thromboembolic events with coronavirus disease 2019 (COVID-19) infection, such as pulmonary embolism, have been described in recent literature as a manifestation in patients during their hospital admission. Our case report describes a delayed manifestation of bilateral pulmonary embolism in a patient who was discharged home. The patient is a 40-year-old COVID-19 positive male that presented to the emergency department eight days after his discharge with shortness of breath and diaphoresis. On triage, the patient was hypoxic and tachycardic, prompting a high index of suspicion for pulmonary embolism. Computed tomographic angiography of the chest was performed confirming the presence of a bilateral pulmonary embolism. Subsequently, the patient was started on heparin and transferred to a tertiary facility for thrombectomy. Pulmonary embolism is a manifestation of acute COVID-19 infection. It is important for clinicians to have an increased suspicion for pulmonary embolism in patients presenting with worsening dyspnea and hypoxia who were recently admitted for acute COVID-19 pneumonia. Patients that were hospitalized for acute presentation of COVID-19 infection should reasonably be considered for extended anticoagulant therapy after discharge.
More Related Videos
Related Concept Videos
Pulmonary Embolism I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management
Pneumothorax-II
Clinical Manifestations:
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

